Results 61 to 70 of about 1,734 (194)
Cytomegalovirus (CMV) infections may increase morbidity and mortality in immunocompromised patients. Until recently, standard antiviral drugs against CMV were limited to viral DNA polymerase inhibitors (val)ganciclovir, foscarnet and cidofovir with a ...
Jocelyne Piret, Guy Boivin
doaj +1 more source
Despite the availability of currently approved antiviral drugs, infections with human cytomegalovirus (HCMV) still cause clinically challenging, sometimes life-threatening situations.
Markus Wild +9 more
doaj +1 more source
Phenotyping of N -acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected? [PDF]
Objectives: Individual activities of N-acetyltransferase 2 (NAT2) and of xanthine oxidase (XO) can be assessed using ratios of urinary caffeine metabolites.
Fuhr, Uwe +5 more
core
Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance [PDF]
Resistant CMV infections are challenging complications after SOT and HSCT. Prompt recognition of ARMs is imperative for appropriate therapy. 108 plasma samples from 96 CMV + transplant recipients with suspected resistance were analysed in CNM in a ...
Gonzalez-Jimenez, Irene +2 more
core +1 more source
Large Language Models for Clinical Trial Protocol Assessments
The purpose was to evaluate the utility of large language models (LLMs) for reviewing the statistical analysis plan (SAP) and pharmacokinetics–pharmacodynamics (PK–PD) components of clinical trial protocols. Clinical trial protocols and SAPs were obtained from clinicaltrials.gov for a testbed of 15 small‐molecule drugs, biologics, and global antibiotic
Euibeom Shin +2 more
wiley +1 more source
The instructional case is a pediatric haploidentical TCRαβ+/CD19+ depleted allogeneic hematopoietic cell transplantation recipient who developed early onset CMV infection, which was complicated by resistant CMV (both UL97 and UL54) and successfully ...
Eunkyung Song, Eunkyung Song
doaj +1 more source
Novel Antiviral Compound shows in-vivo efficacy against Cytomegalovirus [PDF]
Widespread use of Ganciclovir (GCV) therapy has led to resistant strains of cytomegalovirus (CMV), prompting development of new antiviral compounds. A novel duplex compound of Zidovudine and Foscarnet (N3) has shown excellent in-vitro activity against ...
Capone, Jesse
core +1 more source
In vitro assessment of the combined effect of letermovir and sirolimus on cytomegalovirus replication [PDF]
Introduction. Letermovir (LMV) is used for prophylaxis of cytomegalovirus (CMV) reactivation and end-organ disease in adult CMV-seropositive allogeneic hematopoietic stem cell transplant recipients (allo-HSCT).
Aguilar, Cristóbal +7 more
core +1 more source
Intestinal and Multivisceral Transplantation: Where We Stand Today
ABSTRACT Intestinal and multivisceral transplantation has evolved from an experimental to a life‐saving procedure for children and adults with complications of gut failure (GF). Suboptimal long‐term outcomes of transplant elicit recent advances in surgical and medical gut rehabilitation along with the introduction of glucagon‐like peptide‐2 (GLP‐2 ...
Mohamed Maklad +5 more
wiley +1 more source
Diseño, síntesis y caracterización estructural de compuestos derivados de 2-amino-propano-1,3-diol potencialmente activos como antivirales [PDF]
Los adenovirus (AdV) son virus eucariotas con 36000 pares de bases, producen infecciones que son muy comunes y se dan durante todo el año. Las poblaciones susceptibles a la infección por adenovirus (AdV) incluyen niños, pacientes inmunocomprometidos y ...
Muriana Camacho, Claudia
core

